{"entity":{"type":"insider","cik":"0001608936","url":"/insider/0001608936","json_url":"/insider/0001608936.json","name":"Chacko Jacob","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":30,"first":"2014-08-19","last":"2025-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Chacko Jacob","source":"filing","n_filings":30,"first_seen":"2014-08-19","last_seen":"2025-12-17"}],"transactions":[{"id":4070129,"accession":"0001608936-25-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001608936-25-000014","line_url":"/filing/0001608936-25-000014#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33374.0,"shares_display":"33,374","price_per_share":9.06,"price_display":"9.06","price_state":"stated","total_value":302368.44,"total_display":"302,368.44","total_whole":"302,368","shares_owned_after":581711.0,"shares_owned_after_display":"581,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-17","scope":"insider"},{"id":4222053,"accession":"0001608936-25-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001608936-25-000010","line_url":"/filing/0001608936-25-000010#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37461.0,"shares_display":"37,461","price_per_share":12.32,"price_display":"12.32","price_state":"stated","total_value":461519.52,"total_display":"461,519.52","total_whole":"461,520","shares_owned_after":531419.0,"shares_owned_after_display":"531,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"},{"id":4365824,"accession":"0001608936-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001608936-25-000008","line_url":"/filing/0001608936-25-000008#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53001.0,"shares_display":"53,001","price_per_share":12.0527,"price_display":"12.05","price_state":"stated","total_value":638805.1527,"total_display":"638,805.15","total_whole":"638,805","shares_owned_after":568880.0,"shares_owned_after_display":"568,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-02","scope":"insider"},{"id":4365820,"accession":"0001608936-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001608936-25-000008","line_url":"/filing/0001608936-25-000008#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34538.0,"shares_display":"34,538","price_per_share":12.0085,"price_display":"12.01","price_state":"stated","total_value":414749.573,"total_display":"414,749.57","total_whole":"414,750","shares_owned_after":621881.0,"shares_owned_after_display":"621,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4046368,"accession":"0001608936-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001608936-25-000006","line_url":"/filing/0001608936-25-000006#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":10.7995,"price_display":"10.80","price_state":"stated","total_value":1349937.5,"total_display":"1,349,937.50","total_whole":"1,349,938","shares_owned_after":656419.0,"shares_owned_after_display":"656,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-24","scope":"insider"},{"id":2044526,"accession":"0001415889-24-029631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029631","line_url":"/filing/0001415889-24-029631#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24660.0,"shares_display":"24,660","price_per_share":8.2812,"price_display":"8.28","price_state":"stated","total_value":204214.392,"total_display":"204,214.39","total_whole":"204,214","shares_owned_after":778648.0,"shares_owned_after_display":"778,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider"},{"id":2862513,"accession":"0001415889-24-007345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007345","line_url":"/filing/0001415889-24-007345#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":16.2095,"price_display":"16.21","price_state":"stated","total_value":648380.0,"total_display":"648,380.00","total_whole":"648,380","shares_owned_after":728544.0,"shares_owned_after_display":"728,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":2856277,"accession":"0001415889-24-003114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-003114","line_url":"/filing/0001415889-24-003114#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26042.0,"shares_display":"26,042","price_per_share":12.295,"price_display":"12.30","price_state":"stated","total_value":320186.39,"total_display":"320,186.39","total_whole":"320,186","shares_owned_after":768544.0,"shares_owned_after_display":"768,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":2856274,"accession":"0001415889-24-003114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003114","line_url":"/filing/0001415889-24-003114#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13958.0,"shares_display":"13,958","price_per_share":12.1192,"price_display":"12.12","price_state":"stated","total_value":169159.7936,"total_display":"169,159.79","total_whole":"169,160","shares_owned_after":794586.0,"shares_owned_after_display":"794,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":8681844,"accession":"0001209191-23-059263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059263","line_url":"/filing/0001209191-23-059263#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14539.0,"shares_display":"14,539","price_per_share":8.5847,"price_display":"8.58","price_state":"stated","total_value":124812.9533,"total_display":"124,812.95","total_whole":"124,813","shares_owned_after":808544.0,"shares_owned_after_display":"808,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":8629638,"accession":"0001209191-23-042054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042054","line_url":"/filing/0001209191-23-042054#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5156.0,"shares_display":"5,156","price_per_share":8.0076,"price_display":"8.01","price_state":"stated","total_value":41287.1856,"total_display":"41,287.19","total_whole":"41,287","shares_owned_after":780652.0,"shares_owned_after_display":"780,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-11","scope":"insider"},{"id":8629633,"accession":"0001209191-23-042054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042054","line_url":"/filing/0001209191-23-042054#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10508.0,"shares_display":"10,508","price_per_share":8.0141,"price_display":"8.01","price_state":"stated","total_value":84212.1628,"total_display":"84,212.16","total_whole":"84,212","shares_owned_after":785808.0,"shares_owned_after_display":"785,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-11","scope":"insider"},{"id":8022923,"accession":"0001209191-23-041805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041805","line_url":"/filing/0001209191-23-041805#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4336.0,"shares_display":"4,336","price_per_share":8.0052,"price_display":"8.01","price_state":"stated","total_value":34710.5472,"total_display":"34,710.55","total_whole":"34,711","shares_owned_after":796316.0,"shares_owned_after_display":"796,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-07","scope":"insider"},{"id":7998710,"accession":"0001209191-23-040090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040090","line_url":"/filing/0001209191-23-040090#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.0281,"price_display":"8.03","price_state":"stated","total_value":160562.0,"total_display":"160,562.00","total_whole":"160,562","shares_owned_after":800652.0,"shares_owned_after_display":"800,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-28","scope":"insider"},{"id":7894762,"accession":"0001140361-23-020315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-020315","line_url":"/filing/0001140361-23-020315#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"4D Molecular Therapeutics, Inc.","issuer_ticker":"FDMT","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0539,"price_display":"20.05","price_state":"stated","total_value":100269.5,"total_display":"100,269.50","total_whole":"100,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":9271908,"accession":"0001209191-23-010607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010607","line_url":"/filing/0001209191-23-010607#line-1","is_derivative":false,"issuer_cik":"0001796280","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001796280","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6137.0,"shares_display":"6,137","price_per_share":3.073,"price_display":"3.07","price_state":"stated","total_value":18859.001,"total_display":"18,859.00","total_whole":"18,859","shares_owned_after":816652.0,"shares_owned_after_display":"816,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2023-02-17","scope":"insider"},{"id":6958013,"accession":"0001209191-22-061754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-061754","line_url":"/filing/0001209191-22-061754#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5764.0,"shares_display":"5,764","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":18733.0,"total_display":"18,733.00","total_whole":"18,733","shares_owned_after":817025.0,"shares_owned_after_display":"817,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6823464,"accession":"0001209191-22-028963","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-028963","line_url":"/filing/0001209191-22-028963#line-3","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76072.0,"shares_display":"76,072","price_per_share":2.8205,"price_display":"2.82","price_state":"stated","total_value":214561.076,"total_display":"214,561.08","total_whole":"214,561","shares_owned_after":802652.0,"shares_owned_after_display":"802,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-13","scope":"insider"},{"id":6823459,"accession":"0001209191-22-028963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-028963","line_url":"/filing/0001209191-22-028963#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69354.0,"shares_display":"69,354","price_per_share":2.7463,"price_display":"2.75","price_state":"stated","total_value":190466.8902,"total_display":"190,466.89","total_whole":"190,467","shares_owned_after":726580.0,"shares_owned_after_display":"726,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-13","scope":"insider"},{"id":6823453,"accession":"0001209191-22-028963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-028963","line_url":"/filing/0001209191-22-028963#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":304574.0,"shares_display":"304,574","price_per_share":2.901,"price_display":"2.90","price_state":"stated","total_value":883569.174,"total_display":"883,569.17","total_whole":"883,569","shares_owned_after":657226.0,"shares_owned_after_display":"657,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-13","scope":"insider"},{"id":6295660,"accession":"0001209191-22-021153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-021153","line_url":"/filing/0001209191-22-021153#line-3","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.5434,"price_display":"4.54","price_state":"stated","total_value":227170.0,"total_display":"227,170.00","total_whole":"227,170","shares_owned_after":352652.0,"shares_owned_after_display":"352,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-25","scope":"insider"},{"id":6295657,"accession":"0001209191-22-021153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-021153","line_url":"/filing/0001209191-22-021153#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42873.0,"shares_display":"42,873","price_per_share":5.0302,"price_display":"5.03","price_state":"stated","total_value":215659.7646,"total_display":"215,659.76","total_whole":"215,660","shares_owned_after":302652.0,"shares_owned_after_display":"302,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-03-25","scope":"insider"},{"id":6295652,"accession":"0001209191-22-021153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021153","line_url":"/filing/0001209191-22-021153#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":257127.0,"shares_display":"257,127","price_per_share":4.9815,"price_display":"4.98","price_state":"stated","total_value":1280878.1505,"total_display":"1,280,878.15","total_whole":"1,280,878","shares_owned_after":259779.0,"shares_owned_after_display":"259,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-25","scope":"insider"},{"id":4793262,"accession":"0001209191-21-056460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-056460","line_url":"/filing/0001209191-21-056460#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3736.0,"shares_display":"3,736","price_per_share":25.0612,"price_display":"25.06","price_state":"stated","total_value":93628.6432,"total_display":"93,628.64","total_whole":"93,629","shares_owned_after":2652.0,"shares_owned_after_display":"2,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-16","scope":"insider"},{"id":4793258,"accession":"0001209191-21-056460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-056460","line_url":"/filing/0001209191-21-056460#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4420.0,"shares_display":"4,420","price_per_share":25.0467,"price_display":"25.05","price_state":"stated","total_value":110706.414,"total_display":"110,706.41","total_whole":"110,706","shares_owned_after":6388.0,"shares_owned_after_display":"6,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-16","scope":"insider"},{"id":5430246,"accession":"0001209191-21-055866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055866","line_url":"/filing/0001209191-21-055866#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2801.0,"shares_display":"2,801","price_per_share":25.0228,"price_display":"25.02","price_state":"stated","total_value":70088.8628,"total_display":"70,088.86","total_whole":"70,089","shares_owned_after":10808.0,"shares_owned_after_display":"10,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider"},{"id":5430243,"accession":"0001209191-21-055866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055866","line_url":"/filing/0001209191-21-055866#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2942.0,"shares_display":"2,942","price_per_share":25.0793,"price_display":"25.08","price_state":"stated","total_value":73783.3006,"total_display":"73,783.30","total_whole":"73,783","shares_owned_after":13609.0,"shares_owned_after_display":"13,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-14","scope":"insider"},{"id":5384224,"accession":"0001209191-21-055291","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055291","line_url":"/filing/0001209191-21-055291#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":25.035,"price_display":"25.04","price_state":"stated","total_value":5007.0,"total_display":"5,007.00","total_whole":"5,007","shares_owned_after":16551.0,"shares_owned_after_display":"16,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-09","scope":"insider"},{"id":5384221,"accession":"0001209191-21-055291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055291","line_url":"/filing/0001209191-21-055291#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5981.0,"shares_display":"5,981","price_per_share":25.1084,"price_display":"25.11","price_state":"stated","total_value":150173.3404,"total_display":"150,173.34","total_whole":"150,173","shares_owned_after":16751.0,"shares_owned_after_display":"16,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":5292312,"accession":"0001209191-21-036686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036686","line_url":"/filing/0001209191-21-036686#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":10028.0,"total_display":"10,028.00","total_whole":"10,028","shares_owned_after":22732.0,"shares_owned_after_display":"22,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-28","scope":"insider"},{"id":4997767,"accession":"0001209191-21-035523","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-035523","line_url":"/filing/0001209191-21-035523#line-3","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12.0,"shares_display":"12","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":300.0,"total_display":"300.00","total_whole":"300","shares_owned_after":23132.0,"shares_owned_after_display":"23,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-24","scope":"insider"},{"id":4997754,"accession":"0001209191-21-035523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-035523","line_url":"/filing/0001209191-21-035523#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4790.0,"shares_display":"4,790","price_per_share":25.1958,"price_display":"25.20","price_state":"stated","total_value":120687.882,"total_display":"120,687.88","total_whole":"120,688","shares_owned_after":23144.0,"shares_owned_after_display":"23,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-24","scope":"insider"},{"id":4997748,"accession":"0001209191-21-035523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035523","line_url":"/filing/0001209191-21-035523#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2468.0,"shares_display":"2,468","price_per_share":25.0664,"price_display":"25.07","price_state":"stated","total_value":61863.8752,"total_display":"61,863.88","total_whole":"61,864","shares_owned_after":27934.0,"shares_owned_after_display":"27,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"},{"id":5160625,"accession":"0001209191-21-033813","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-033813","line_url":"/filing/0001209191-21-033813","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11332.0,"shares_display":"11,332","price_per_share":25.382434309918814,"price_display":"25.38","price_state":"stated","total_value":287633.7456,"total_display":"287,633.75","total_whole":"287,634","shares_owned_after":30602.0,"shares_owned_after_display":"30,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-18","scope":"insider","n_lines":2},{"id":5160612,"accession":"0001209191-21-033813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-033813","line_url":"/filing/0001209191-21-033813#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2550.0,"shares_display":"2,550","price_per_share":25.0526,"price_display":"25.05","price_state":"stated","total_value":63884.13,"total_display":"63,884.13","total_whole":"63,884","shares_owned_after":41734.0,"shares_owned_after_display":"41,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"},{"id":5160605,"accession":"0001209191-21-033813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033813","line_url":"/filing/0001209191-21-033813#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13896.0,"shares_display":"13,896","price_per_share":25.3645,"price_display":"25.36","price_state":"stated","total_value":352465.092,"total_display":"352,465.09","total_whole":"352,465","shares_owned_after":44284.0,"shares_owned_after_display":"44,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":4784910,"accession":"0001209191-21-032508","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-032508","line_url":"/filing/0001209191-21-032508#line-3","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":730.0,"shares_display":"730","price_per_share":25.0425,"price_display":"25.04","price_state":"stated","total_value":18281.025,"total_display":"18,281.02","total_whole":"18,281","shares_owned_after":58180.0,"shares_owned_after_display":"58,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-13","scope":"insider"},{"id":4784905,"accession":"0001209191-21-032508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032508","line_url":"/filing/0001209191-21-032508#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":25.024,"price_display":"25.02","price_state":"stated","total_value":10009.6,"total_display":"10,009.60","total_whole":"10,010","shares_owned_after":58910.0,"shares_owned_after_display":"58,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4784896,"accession":"0001209191-21-032508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032508","line_url":"/filing/0001209191-21-032508#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1090.0,"shares_display":"1,090","price_per_share":25.2198,"price_display":"25.22","price_state":"stated","total_value":27489.582,"total_display":"27,489.58","total_whole":"27,490","shares_owned_after":59310.0,"shares_owned_after_display":"59,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5379929,"accession":"0001209191-21-029375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-029375","line_url":"/filing/0001209191-21-029375#line-2","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":25.2383,"price_display":"25.24","price_state":"stated","total_value":15142.98,"total_display":"15,142.98","total_whole":"15,143","shares_owned_after":60400.0,"shares_owned_after_display":"60,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-04-30","scope":"insider"},{"id":5379925,"accession":"0001209191-21-029375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-029375","line_url":"/filing/0001209191-21-029375#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":25.0596,"price_display":"25.06","price_state":"stated","total_value":17541.72,"total_display":"17,541.72","total_whole":"17,542","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-28","filed_date":"2021-04-30","scope":"insider"},{"id":4529426,"accession":"0001209191-21-025492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-025492","line_url":"/filing/0001209191-21-025492#line-1","is_derivative":false,"issuer_cik":"0001608936","issuer_name":"Oric Pharmaceuticals, Inc.","issuer_ticker":"ORIC","issuer_name_source":null,"issuer_url":"/issuer/0001608936","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":25.087,"price_display":"25.09","price_state":"stated","total_value":20069.6,"total_display":"20,069.60","total_whole":"20,070","shares_owned_after":61700.0,"shares_owned_after_display":"61,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":3172111,"accession":"0001209191-16-109687","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109687","line_url":"/filing/0001209191-16-109687#line-1","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.635,"price_display":"5.64","price_state":"stated","total_value":56350.0,"total_display":"56,350.00","total_whole":"56,350","shares_owned_after":42838.0,"shares_owned_after_display":"42,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-17","filed_date":"2016-03-21","scope":"insider"},{"id":8255945,"accession":"0001209191-15-085727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-085727","line_url":"/filing/0001209191-15-085727#line-1","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":6438.0,"shares_owned_after_display":"6,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2015-12-17","scope":"insider"},{"id":9269713,"accession":"0001209191-15-068277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-068277","line_url":"/filing/0001209191-15-068277#line-1","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":18600.0,"total_display":"18,600.00","total_whole":"18,600","shares_owned_after":4938.0,"shares_owned_after_display":"4,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-27","scope":"insider"},{"id":6388833,"accession":"0001209191-14-070947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070947","line_url":"/filing/0001209191-14-070947#line-2","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":930.0,"shares_display":"930","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":6045.0,"total_display":"6,045.00","total_whole":"6,045","shares_owned_after":3438.0,"shares_owned_after_display":"3,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-24","scope":"insider"},{"id":6388830,"accession":"0001209191-14-070947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-070947","line_url":"/filing/0001209191-14-070947#line-1","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":668.0,"shares_display":"668","price_per_share":6.4,"price_display":"6.40","price_state":"stated","total_value":4275.2,"total_display":"4,275.20","total_whole":"4,275","shares_owned_after":2508.0,"shares_owned_after_display":"2,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-24","scope":"insider"},{"id":6530821,"accession":"0001209191-14-053500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-053500","line_url":"/filing/0001209191-14-053500#line-2","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1540.0,"shares_display":"1,540","price_per_share":7.53,"price_display":"7.53","price_state":"stated","total_value":11596.2,"total_display":"11,596.20","total_whole":"11,596","shares_owned_after":1840.0,"shares_owned_after_display":"1,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-19","filed_date":"2014-08-19","scope":"insider"},{"id":6530818,"accession":"0001209191-14-053500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-053500","line_url":"/filing/0001209191-14-053500#line-1","is_derivative":false,"issuer_cik":"0001557421","issuer_name":"Ignyta, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001557421","owner_cik":"0001608936","owner_name":"Chacko Jacob","owner_display_name":"Chacko Jacob","owner_url":"/insider/0001608936","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":2250.0,"total_display":"2,250.00","total_whole":"2,250","shares_owned_after":300.0,"shares_owned_after_display":"300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796280","name":"Oric Pharmaceuticals, Inc.","url":"/issuer/0001796280","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":24,"first_seen":"2021-04-05","last_seen":"2025-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001650648","name":"4D Molecular Therapeutics, Inc.","url":"/issuer/0001650648","role":"Director","n_filings":1,"first_seen":"2023-04-25","last_seen":"2023-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001557421","name":"Ignyta, Inc.","url":"/issuer/0001557421","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2014-08-19","last_seen":"2016-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001608936","retrieved_at":"2026-08-22T08:40:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}